文献速递临床微生物质量管理与危急值

纽约市COVID-19疫情期间菌血症与血培养利用情况

Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City.
PubMed 文献 · J Clin Microbiol · 2020-07-23

该研究对纽约市多中心医院网络中28,011例患者的88,201份血培养进行回顾性队列分析,评估疫情期间血培养的开单量、阳性率、阳性报告时间及病原谱。结果显示2020年3月下半月开单量较上半月增加34.8%,COVID-19患者菌血症率(3.8%)显著低于阴性患者(8.0%)和未检测者(7.1%)(P < 0.001),提示应审慎使用血培养。

要点

  • COVID-19患者菌血症率3.8%,显著低于阴性者8.0%和未检测者7.1%(P < 0.001)
  • COVID-19患者阳性培养中皮肤共生菌比例高,排除后菌血症率降至1.6%
  • 超过98%的阳性培养在孵育4天内检出,必要时可将孵育期由5天缩短至4天

核心结论

  • COVID-19患者血流感染非常罕见,支持在缺乏明确细菌合并感染证据时审慎使用血培养。
  • 需与开单医生清晰沟通以防患者激增期间血培养过度使用。
  • 实验室可考虑将孵育期由5天缩短至4天以释放额外检测能力。

研究设计与样本

  • 对纽约市多中心医院网络中28,011例患者的88,201份血培养进行回顾性队列分析。
  • 评估指标包括开单量、阳性率、阳性报告时间和阳性培养病原谱。

主要发现

  • 2020年3月下半月血培养开单量较上半月增加34.8%。
  • COVID-19患者菌血症率为3.8%,低于COVID-19阴性患者的8.0%和未检测者的7.1%(P < 0.001)。
  • COVID-19患者阳性培养中皮肤共生菌比例高,排除后菌血症率降至1.6%。
  • 超过98%的阳性培养在孵育4天内检出。

关键数值与推荐

  • COVID-19患者菌血症率3.8%,阴性患者8.0%,未检测者7.1%(P < 0.001)。
  • 排除皮肤共生菌后COVID-19患者菌血症率降至1.6%。
  • 超过98%的阳性培养在孵育4天内检出。

临床怎么用

  • 在缺乏明确细菌合并感染证据时,对COVID-19患者审慎开具血培养。
  • 患者激增期间加强与开单医生的沟通,防止血培养过度使用。
  • 实验室必要时可将血培养孵育期由5天缩短至4天以释放检测能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A surge of patients with coronavirus disease 2019 (COVID-19) presenting to New York City hospitals in March 2020 led to a sharp increase in blood culture utilization, which overwhelmed the capacity of automated blood culture instruments. We sought to evaluate the utilization and diagnostic yield of blood cultures during the COVID-19 pandemic to determine prevalence and common etiologies of bacteremia and to inform a diagnostic approach to relieve blood culture overutilization. We performed a retrospective cohort analysis of 88,201 blood cultures from 28,011 patients at a multicenter network of hospitals within New York City to evaluate order volume, positivity rate, time to positivity, and etiologies of positive cultures in COVID-19. Ordering volume increased by 34.8% in the second half of March 2020 compared to the level in the first half of the month. The rate of bacteremia was significantly lower among COVID-19 patients (3.8%) than among COVID-19-negative patients (8.0%) and those not tested (7.1%) (P < 0.001). COVID-19 patients had a high proportion of organisms reflective of commensal skin microbiota, which, when excluded, reduced the bacteremia rate to 1.6%. More than 98% of all positive cultures were detected within 4 days of incubation. Bloodstream infections are very rare for COVID-19 patients, which supports the judicious use of blood cultures in the absence of compelling evidence for bacterial coinfection. Clear communication with ordering providers is necessary to prevent overutilization of blood cultures during patient surges, and laboratories should consider shortening the incubation period from 5 days to 4 days, if necessary, to free additional capacity.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Sepulveda J, Westblade LF, Whittier S, et al. Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City. J Clin Microbiol. 2020. PMID: 32404482. doi:10.1128/JCM.00875-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。